AI
BTAL icon

AXS Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

AXS Investments’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,955
Closed -$508K – 311
2023
Q4 		$508K Sell
29,955
-11,620
-28% -$231K 0.12% 224
2023
Q3 		$826K Sell
41,575
-265
-0.6% -$5.02K 0.21% 164
2023
Q2 		$785K Buy
41,840
+40,317
+2,647% +$813K 0.21% 167
2023
Q1 		$31.1K Sell
1,523
-2,113
-58% -$42.5K 0.01% 325
2022
Q4 		$77.1K Buy
+3,636
New +$75.4K 0.03% 247

Other funds holding BTAL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TA
Tactive Advisors Jacksonville, Florida $406M AUM 35.68% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

AXS Investments's BTAL Position: Q1 2024 in Review

AXS Investments sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2024, closing a stake of 29,955 shares — an estimated $508K sold.

AXS Investments first reported a position in BTAL in Q4 2022 and held it in 5 quarters. The position peaked at $826K in Q3 2023. 61 funds tracked by Wall St. Rank hold BTAL as of Q1 2024.

  • AXS Investments reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2024 after selling out during the quarter.
  • AXS Investments sold 29,955 AGF US Market Neutral Anti-Beta Fund shares in Q1 2024, an estimated $508K.
  • AXS Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 5 quarters.
  • AXS Investments's AGF US Market Neutral Anti-Beta Fund position peaked at $826K in Q3 2023.
  • 61 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.